111 related articles for article (PubMed ID: 18510366)
1. Structure-based drug design: exploring the proper filling of apolar pockets at enzyme active sites.
Zürcher M; Diederich F
J Org Chem; 2008 Jun; 73(12):4345-61. PubMed ID: 18510366
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of cytidine derivatives that inhibit the kinase IspE of the non-mevalonate pathway for isoprenoid biosynthesis.
Crane CM; Hirsch AK; Alphey MS; Sgraja T; Lauw S; Illarionova V; Rohdich F; Eisenreich W; Hunter WN; Bacher A; Diederich F
ChemMedChem; 2008 Jan; 3(1):91-101. PubMed ID: 18033714
[TBL] [Abstract][Full Text] [Related]
3. Think twice: understanding the high potency of bis(phenyl)methane inhibitors of thrombin.
Baum B; Muley L; Heine A; Smolinski M; Hangauer D; Klebe G
J Mol Biol; 2009 Aug; 391(3):552-64. PubMed ID: 19520086
[TBL] [Abstract][Full Text] [Related]
4. Molecular recognition at the active site of factor Xa: cation-π interactions, stacking on planar peptide surfaces, and replacement of structural water.
Salonen LM; Holland MC; Kaib PS; Haap W; Benz J; Mary JL; Kuster O; Schweizer WB; Banner DW; Diederich F
Chemistry; 2012 Jan; 18(1):213-22. PubMed ID: 22162109
[TBL] [Abstract][Full Text] [Related]
5. Multipolar interactions in the D pocket of thrombin: large differences between tricyclic imide and lactam inhibitors.
Schweizer E; Hoffmann-Röder A; Olsen JA; Seiler P; Obst-Sander U; Wagner B; Kansy M; Banner DW; Diederich F
Org Biomol Chem; 2006 Jun; 4(12):2364-75. PubMed ID: 16763681
[TBL] [Abstract][Full Text] [Related]
6. Probing the S2 site of factor VIIa to generate potent and selective inhibitors: the structure of BCX-3607 in complex with tissue factor-factor VIIa.
Krishnan R; Kotian PL; Chand P; Bantia S; Rowland S; Babu YS
Acta Crystallogr D Biol Crystallogr; 2007 Jun; 63(Pt 6):689-97. PubMed ID: 17505107
[TBL] [Abstract][Full Text] [Related]
7. Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations.
Durdagi S; Mavromoustakos T; Chronakis N; Papadopoulos MG
Bioorg Med Chem; 2008 Dec; 16(23):9957-74. PubMed ID: 18996019
[TBL] [Abstract][Full Text] [Related]
8. A fluorine scan of thrombin inhibitors to map the fluorophilicity/fluorophobicity of an enzyme active site: evidence for C-F...C=O interactions.
Olsen JA; Banner DW; Seiler P; Obst Sander U; D'Arcy A; Stihle M; Müller K; Diederich F
Angew Chem Int Ed Engl; 2003 Jun; 42(22):2507-11. PubMed ID: 12800172
[No Abstract] [Full Text] [Related]
9. Picking pockets to fuel antimicrobial drug discovery.
Hunter WN
Biochem Soc Trans; 2007 Nov; 35(Pt 5):980-4. PubMed ID: 17956259
[TBL] [Abstract][Full Text] [Related]
10. Comparative studies on inhibitors of HIV protease: a target for drug design.
Jayaraman S; Shah K
In Silico Biol; 2008; 8(5-6):427-47. PubMed ID: 19374129
[TBL] [Abstract][Full Text] [Related]
11. An integrated approach to ligand- and structure-based drug design: development and application to a series of serine protease inhibitors.
Nicolotti O; Miscioscia TF; Carotti A; Leonetti F; Carotti A
J Chem Inf Model; 2008 Jun; 48(6):1211-26. PubMed ID: 18540590
[TBL] [Abstract][Full Text] [Related]
12. Bisubstrate inhibitors of catechol O-methyltransferase (COMT): the crucial role of the ribose structural unit for inhibitor binding affinity.
Paulini R; Trindler C; Lerner C; Brändli L; Schweizer WB; Jakob-Roetne R; Zürcher G; Borroni E; Diederich F
ChemMedChem; 2006 Mar; 1(3):340-57. PubMed ID: 16892369
[TBL] [Abstract][Full Text] [Related]
13. Mapping the fluorophilicity of a hydrophobic pocket: synthesis and biological evaluation of tricyclic thrombin inhibitors directing fluorinated alkyl groups into the p pocket.
Hoffmann-Röder A; Schweizer E; Egger J; Seiler P; Obst-Sander U; Wagner B; Kansy M; Banner DW; Diederich F
ChemMedChem; 2006 Nov; 1(11):1205-15. PubMed ID: 17001711
[TBL] [Abstract][Full Text] [Related]
14. A fluorine scan of the phenylamidinium needle of tricyclic thrombin inhibitors: effects of fluorine substitution on pKa and binding affinity and evidence for intermolecular C-F...CN interactions.
Olsen J; Seiler P; Wagner B; Fischer H; Tschopp T; Obst-Sander U; Banner DW; Kansy M; Müller K; Diederich F
Org Biomol Chem; 2004 May; 2(9):1339-52. PubMed ID: 15105924
[TBL] [Abstract][Full Text] [Related]
15. Crystal structures of rat catechol-O-methyltransferase complexed with coumarine-based inhibitor.
Tsuji E; Okazaki K; Takeda K
Biochem Biophys Res Commun; 2009 Jan; 378(3):494-7. PubMed ID: 19056347
[TBL] [Abstract][Full Text] [Related]
16. Computer-aided design and synthesis of nonpeptidic plasmepsin II and IV inhibitors.
Luksch T; Chan NS; Brass S; Sotriffer CA; Klebe G; Diederich WE
ChemMedChem; 2008 Sep; 3(9):1323-36. PubMed ID: 18752222
[TBL] [Abstract][Full Text] [Related]
17. Development of selective bisubstrate-based inhibitors against protein kinase C (PKC) isozymes by using dynamic peptide microarrays.
Poot AJ; van Ameijde J; Slijper M; van den Berg A; Hilhorst R; Ruijtenbeek R; Rijkers DT; Liskamp RM
Chembiochem; 2009 Aug; 10(12):2042-51. PubMed ID: 19618415
[TBL] [Abstract][Full Text] [Related]
18. Next generation chemical proteomic tools for rapid enzyme profiling.
Uttamchandani M; Lu CH; Yao SQ
Acc Chem Res; 2009 Aug; 42(8):1183-92. PubMed ID: 19435360
[TBL] [Abstract][Full Text] [Related]
19. Dimethylthiazolidine carboxylic acid as a rigid p3 unit in inhibitors of serine proteases: application to two targets.
Kawai SH; Aubry N; Duceppe JS; Llinàs-Brunet M; LaPlante SR
Chem Biol Drug Des; 2009 Nov; 74(5):517-22. PubMed ID: 19780760
[TBL] [Abstract][Full Text] [Related]
20. Compounds binding to the S2-S3 pockets of thrombin.
Nilsson M; Hämäläinen M; Ivarsson M; Gottfries J; Xue Y; Hansson S; Isaksson R; Fex T
J Med Chem; 2009 May; 52(9):2708-15. PubMed ID: 19371038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
